Search results
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 3 days agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
Traders Brace for a Big Swing in Nvidia Stock After Earnings
The Wall Street Journal· 4 days agoTraders are betting on another mammoth move in Nvidia shares after the chip company posts earnings...
JHG vs. BLK: Which Stock Is the Better Value Option?
Zacks· 6 days agoInvestment Management stocks have likely encountered both Janus Henderson Group plc (JHG Quick QuoteJHG - Free Report) and BlackRock (BLK Quick QuoteBLK ...
Bilibili (NASDAQ:BILI) Trading Up 4%
ETF DAILY NEWS· 2 days agoShares of Bilibili Inc. (NASDAQ:BILI – Get Free Report) rose 4% during mid-day trading on Wednesday . Barclays raised Bilibili from an “underweight” rating to an “equal weight” rating and upped ...
Make the Most of Your Retirement with These Top-Ranked Mutual Funds
Zacks via Yahoo Finance· 6 days agoConsider adding these three top-ranked, best-performing and well-managed mutual funds to your...
CAE (NYSE:CAE) Downgraded to Hold at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com downgraded shares of CAE (NYSE:CAE – Free Report) (TSE:CAE) from a buy rating to a hold rating in a research note published on Wednesday morning. Canaccord Genuity Group reissued ...
Gildan’s Entire Board Resigns, Handing Victory to Activist Browning West
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Gildan Activewear Inc.’s entire board of directors and Chief Executive Officer Vince...
EBay Stock Breaks Out To New Highs As Financial Firm Tops Buy Point, Too
Investor's Business Daily· 2 days agoEBay jumped into a buy zone from a flat-base buy point of 52.93 as shares rallied to levels last...
Vita Coco (NASDAQ:COCO) Stock Rating Reaffirmed by Stephens
ETF DAILY NEWS· 1 day agoVita Coco (NASDAQ:COCO – Get Free Report)‘s stock had its “overweight” rating reissued by stock...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 3 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...